Describe the mechanisms of action, pharmacokinetics, adverse effects and limitations of drugs used in the treatment of Parkinson’s disease (e.g. L-DOPA, dopaminergic agonists, cholinergic antagonists, MAOB inhibitors).
Level
This learning outcome is a primary level outcome.
